108 related articles for article (PubMed ID: 17241781)
1. Selective analogs of 1alpha,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D.
DeLuca HF; Plum LA; Clagett-Dame M
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):263-8. PubMed ID: 17241781
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1alpha,25-dihydroxyvitamin D3.
DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):67-73. PubMed ID: 15225749
[TBL] [Abstract][Full Text] [Related]
3. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
4. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 analogs for the treatment of osteoporosis.
Hagino H
Can J Physiol Pharmacol; 2015 May; 93(5):327-32. PubMed ID: 25853632
[TBL] [Abstract][Full Text] [Related]
6. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
Zella JB; Plum LA; Plowchalk DR; Potochoiba M; Clagett-Dame M; DeLuca HF
Am J Nephrol; 2014; 39(6):476-83. PubMed ID: 24854296
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of Vitamin D analogs on bone formation and resorption.
Nakane M; Fey TA; Dixon DB; Ma J; Brune ME; Li YC; Wu-Wong JR
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):72-7. PubMed ID: 16242929
[TBL] [Abstract][Full Text] [Related]
9. The development of a bone- and parathyroid-specific analog of vitamin D: 2-methylene-19-Nor-(20S)-1α,25-dihydroxyvitamin D3.
Deluca HF
Bonekey Rep; 2014; 3():514. PubMed ID: 24818006
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Activity of 25-Hydroxy-2-methylene-vitamin D3 analogues monohydroxylated in the A-ring.
Sibilska IK; Sicinski RR; Ochalek JT; Plum LA; DeLuca HF
J Med Chem; 2014 Oct; 57(20):8319-31. PubMed ID: 25221942
[TBL] [Abstract][Full Text] [Related]
11. Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.
Barycki R; Sicinski RR; Plum LA; Grzywacz P; Clagett-Dame M; Deluca HF
Bioorg Med Chem; 2009 Nov; 17(22):7658-69. PubMed ID: 19819702
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds.
Sibilska IK; Szybinski M; Sicinski RR; Plum LA; DeLuca HF
J Med Chem; 2015 Dec; 58(24):9653-62. PubMed ID: 26574921
[TBL] [Abstract][Full Text] [Related]
13. 26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25-dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo.
Grzywacz P; Plum LA; Clagett-Dame M; DeLuca HF
Bioorg Chem; 2013 Apr; 47():9-16. PubMed ID: 23474215
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 25-hydroxy-2-methylene-vitamin D3 compounds.
Sibilska I; Sicinski RR; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2013 Jul; 136():17-22. PubMed ID: 23274116
[TBL] [Abstract][Full Text] [Related]
15. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
16. Differential recruitment of coactivators to the vitamin D receptor transcriptional complex by 1alpha,25-dihydroxyvitamin D3 analogs.
Schwinn MK; DeLuca HF
Arch Biochem Biophys; 2007 Sep; 465(2):443-51. PubMed ID: 17658451
[TBL] [Abstract][Full Text] [Related]
17. Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1alpha,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity.
Grzywacz P; Plum LA; Sicinski RR; Clagett-Dame M; DeLuca HF
Arch Biochem Biophys; 2007 Apr; 460(2):274-84. PubMed ID: 17094936
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
Ono Y
J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
[TBL] [Abstract][Full Text] [Related]
19. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and bone.
Suda T; Ueno Y; Fujii K; Shinki T
J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
